




Hypovolemic shock in Adults (at a glance) 
 
Introduction 
This article introduces the reader to hypovolemic shock. It discusses the risk factors, 
aetiology, investigations, staging, complications, principles of management, 
education and training, for hypovolemic shock.  
 
Shock  
Shock is generally classified according to its cause. There are four main pathological 
mechanisms that can result in a state of shock (Vincent and De Backer, 2013; 
Straton, 2017), being: hypovolemia (loss of intravascular volume form internal or 
external fluid loss, cardiogenic (pump failure), obstruction (barriers to cardiac filling 
or circulatory flow); and distributive shock (dur to vaso-regulation and loss of 
vascular tone).  
Shock is most commonly defined as ‘the life-threatening failure of adequate oxygen 
delivery to the tissues and may be due to decreased blood perfusion of tissues, 
inadequate blood oxygen saturation, or increased oxygen demand from the tissues 
that results in decreased end-organ oxygenation and dysfunction’ (Stratton, 2019). If 
left untreated, shock results in sustained multiple organ dysfunction, and end-organ 
damage with possible death. Tissue hypoperfusion may be present without systemic 
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hypotension, but at the bedside shock is commonly diagnosed when both are 
present (arterial hypotension and organ dysfunction) (Stratton, 2019).  
 
 
Hypovolemic Shock  
Hypovolaemic shock is characterised by a loss of intavascular volume of 15% or 
more leading to inadequate perfusion of the tissues (Peate, 2020). Hypovolemic 
shock occurs when the volume of the circulatory system is too depleted to allow 
adequate circulation to the tissues of the body (Rull and Bonsall, 2017). In summary, 
hypo means low, vol means volume and anaemic means blood translating as low 
blood volume. Patients with hypovolemic shock have severe hypovolemia with 
decreased peripheral perfusion. If left untreated, these patients can develop 
ischemic injury of vital organs, leading to multi-system organ failure. The first factor 
to be considered is whether the hypovolemic shock has resulted from haemorrhage 
or fluid losses, as this will dictate treatment.  
Pathophysiology and symptoms  
Hypovolemic shock results from depletion of intravascular volume, either by blood 
loss or extracellular fluid loss. The body compensates for this with increased 
sympathetic tone resulting in increased heart rate and cardiac contractility, and 
peripheral vasoconstriction. Changes in vital signs include; increase in diastolic 
blood pressure with narrowed pulse pressure. As volume status decreases, systolic 
blood pressure drops. Oxygen delivery to vital organs is unable to meet oxygen 
demand as a result and cells switch from aerobic metabolism to anaerobic 
metabolism, resulting in lactic acidosis. Blood flow is diverted from other organs to 
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preserve blood flow to the heart and brain as sympathetic drive increases. This 
propagates tissue ischemia and worsens lactic acidosis. If this is not corrected, there 
will be worsening hemodynamic compromise and, eventually, death (Gayet_Ageron 
et al., 2018) 
Symptoms of hypovolemic shock can be related to volume depletion, electrolyte 
imbalances or acid base disorders that accompany hypovolemic shock. Patients with 
volume depletion may experience thirst, muscle cramps and/or orthostatic 
hypotension (decrease in systolic blood pressure of 20mmHG or decrease in 
diastolic blood pressure of 10mmHG within three minutes of standing compared to a 
sitting or supine blood pressure). In severe hypovolemic shock patients can 
experience abdominal or chest pain caused by mesenteric and coronary ischemia. 
Brain malperfusion can cause agitation, lethargy or confusion. Physical assessments 
as a result of volume depletion may find dry mucous membranes, decreased skin 
elasticity, low jugular venous distention. Tachycardia, hypotension and decreased 
urinary output. Patients can also appear cold, clammy and cyanotic (Annane et al., 
2013). 
 
Risk factors  
A healthy adult can withstand the loss of half a litre from a circulation of about five 
litres without ill effect (Rull and Bonsall, 2017); however, larger volumes and rapid 
loss cause progressively greater problems. Risk is very much related to the degree 
of hypovolaemia and the speed of correction. In children and young adults’ 
tachycardia is one of the earliest signs of hypovolaemia as the circulatory system is 
much better able to cope with the rigours of loss. The risk of morbidity and mortality 
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is much greater as age increases because they often do not tolerate having low 
blood volume (Rull and Bonsall, 2017). Pathology in the cardiovascular, respiratory 
and renal systems increases risk. 
 
Aetiology  
The annual incidence of shock of any aetiology is 0.3 to 0.7 per 1000, with 
haemorrhagic shock being most common in the intensive care unit (Taghavi and 
Askari, 2019). Hypovolemic shock is the most common type of shock in children, 
most commonly due to diarrheal illness in the developing world. Hypovolemic shock 
occurs as a result of either blood loss or extracellular fluid loss. Haemorrhagic shock 
is hypovolemic shock from blood loss. Traumatic injury is by far the most common 
cause of haemorrhagic shock. Other causes of haemorrhagic shock include 
gastrointestinal (GI) bleed, bleed from an ectopic pregnancy, bleeding from surgical 
intervention, or vaginal bleeding (Taghavi and Askari, 2019). 
 




GI losses can occur via many different aetiologies. The gastrointestinal tract usually 
secretes between 3 to 6 litres of fluid per day. However, most of this fluid is 
reabsorbed as only 100 to 200 mL are lost in the stool. Volume depletion occurs 
when the fluid ordinarily secreted by the GI tract cannot be reabsorbed. This occurs 
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when there is retractable vomiting, diarrhoea, or external drainage via stoma or 
fistulas. (Taghavi and Askari, 2019). 
Renal Losses 
Renal losses of salt and fluid can lead to hypovolemic shock. The kidneys usually 
excrete sodium and water in a manner that matches intake. Diuretic therapy and 
osmotic diuresis from hyperglycaemia can lead to excessive renal sodium and 
volume loss. In addition, there are several tubular and interstitial diseases beyond 
the scope of this article that cause severe salt-wasting nephropathy (Taghavi and 
Askari, 2019). 
Skin Losses 
Fluid loss also can occur from the skin. In a hot and dry climate, skin fluid losses can 
be as high as 1 to 2 litres/hour. Patients with a skin barrier interrupted by burns or 
other skin lesions also can experience large fluid losses that lead to hypovolemic 
shock (Taghavi and Askari, 2019). 
Third-Space Sequestration 
Sequestration of fluid into a third-space also can lead to volume loss and 
hypovolemic shock. Third-spacing of fluid can occur in intestinal obstruction, 
pancreatitis, obstruction of a major venous system, or any other pathological 
condition that results in a massive inflammatory response (Taghavi and Askari, 
2019). 
Blood Work  
Monitoring electrolytes and acid/base status in patients in hypovolemic shock is of 
utmost importance. Biochemical analysis will identify any electrolyte and acid-base 
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disturbances for example contraction alkalosis, metabolic acidosis which could affect 
choice of replacement fluid and rate of repletion. In some cases arterial blood gas is 
needed if mixed acid-base disturbance is suspected (Galvagno, 2014) 
 
Multiple organ dysfunction syndrome (MODS) (Procter, 2019) 
The combination of direct and reperfusion injury may cause MODS—the progressive 
dysfunction of ≥ 2 organs consequent to life-threatening illness or injury (Procter, 
2019). MODS can follow any type of shock but is most common when infection is 
involved; organ failure is one of the defining features of septic shock. MODS also 
occurs in > 10% of patients with severe traumatic injury and is the primary cause of 
death in those surviving > 24 hours (Procter, 2019). 
 
Any organ system can be affected, but the most frequent target organ is the lung, in 
which increased membrane permeability leads to flooding of alveoli and further 
inflammation. Lactate production and metabolic acidosis produces abnormal levels 
of hydrogen ions. This decreases the PH in the blood and the level of bicarbonate. In 
order to compensate, respiratory rate is increased resulting in hyperventilation 
(Galvagno, 2014). Progressive hypoxia may be increasingly resistant to 
supplemental oxygen therapy. This condition is termed acute lung injury or, if severe, 
acute respiratory distress syndrome (ARDS) (Procter, 2019). 
 
The kidneys are injured when renal perfusion is critically reduced, leading to acute 
tubular necrosis and renal insufficiency manifested by oliguria and progressive rise in 




In the heart, reduced coronary perfusion and increased mediators (including tumor 
necrosis factor and interleukin-1) may depress contractility, worsen myocardial 
compliance, and down-regulate beta-receptors. These factors decrease cardiac 
output, further worsening both myocardial and systemic perfusion and causing a 
vicious circle often culminating in death. Arrhythmias may occur what ones? 
(Procter, 2019). 
 
In the gastrointestinal tract, ileus and submucosal hemorrhage can develop. Liver 
hypoperfusion can cause focal or extensive hepatocellular necrosis, transaminase 
and bilirubin elevation, and decreased production of clotting factors (Procter, 2019). 
 
Coagulation can be impaired, including the most severe manifestation, disseminated 
intravascular coagulopathy (Procter, 2019). 
Investigations (Rull and Bonsall, 2017)  
 
Investigation  Rationale  
Check Haemaglobin (Hb), Urea and 
Electrolytes (U&E), Liver Function Test 
(LFT) and, in haemorrhage and burns, 
group and save and crossmatch 
 
There is likely to be a significant drop in 
Hb in early stages of shock.  
 
Prompt administration of blood is 
essential in instances of severe or 








Blood gases – arterial blood gas (ABG) 
or venous blood gas (VBG)  
 
These may show a metabolic acidaemia 
from poor perfusion; lactate levels 
particularly reflect hypoperfusion. Note: 
In clinical practice, an ABG is always 
preferred as the respiratory component 
is captured, and with patients who are in 
shock, it is inevitable that they will 
deteriorate.   
Monitor urine output, which may require 
a catheter. 
 
Urine output should be used to guide 
administration of fluids.  
Ultrasound  This can be useful for differentiating 
hypovolaemic from cardiogenic shock; 
the vena cava can be assessed for 
adequate filling and echocardiogram 
can show any pump failure. 
 
Central venous pressure (CVP)  Monitoring CVP may be useful where 










Lavoie, (2018) recognises that there are four stages of hypovolemic shock based on 
how much blood volume has been lost. All stages require early treatment, but it is 
helpful to recognise the stage of hypovolemia a person is in, so they receive 
appropriate treatment quickly. 
Stage 1 
During the earliest stage of hypovolemic shock, a person with will have lost up to 15 
percent, or 750 ml, of their blood volume. This stage can be difficult to diagnose. 
Blood pressure, urine output and  breathing will still be normal. The most noticeable 
symptom at this stage is skin that appears pale. The person may also experience 
sudden anxiety. 
Stage 2 
In the second stage, the body has lost up to 30 percent, or 1500 ml, of blood. The 
individual may experience increased heart and breathing rates. Blood pressure may 
still be within normal range. However, the diastolic pressure, or bottom number, of 
their blood pressure may be high. The person may begin sweating and feeling more 
anxious and restless. Capillary refill is delayed. Urine output of about 20-30 
millilitres/hour. 
Stage 3 
By stage 3, a person with hypovolemic shock will have 30 to 40 percent, or 1500 to 
2000 ml, blood loss. The top number or systolic pressure of their blood pressure will 
be 100 mm Hg or lower. Their heart rate will increase to over 120 beats per minute 
(bpm). They will also have a rapid breathing rate of over 30 breaths per minute. They 
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will begin to experience mental distress, including anxiety and agitation. The skin will 
be pale and cold, and they will begin sweating. Urine output drops to 20 




A person with stage-4 hypovolemia faces a critical situation. They will have 
experienced a loss of blood volume greater than 40 percent, or 2,000 ml. They will 
have a weak pulse but extremely rapid heart rate. Breathing will become be very fast 
and difficult. Systolic blood pressure will be under 70 millimetres of mercury 
(mm/Hg). They may experience the following symptoms: 
1. drifting in and out of consciousness 
2. sweating heavily 
3. feeling cool to the touch 
4. looking extremely pale 
5. Absent capillary refill  
6. Negligible urine output 
 
Principle of Managing Hypovolemic Shock  
Management of hypovolemia involves assessing and treating the underlying cause, 
identifying electrolyte and acid-base disturbances, and assessing and treating the 
volume deficit, all of which influence the choice of fluid and rate at which it should be 
administered (Mandel and Palevsky, 2019). 
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Clinicians should identify the aetiology (or aetiologies) contributing to hypovolemia so 
that therapies can be directed at the underlying cause of volume loss. Potential 
aetiologies of hypovolemia include gastrointestinal, renal, skin, haemorrhage, and 
third-space losses. Therapies may include anti-emetics to treat vomiting, cessation 
of diuretics, or controlling bleeding. Further details regarding aetiology and diagnosis 
of hypovolemia are discussed separately.  
Identify electrolyte and acid-base disturbances — Biochemical analysis will alert the 
clinician to electrolyte (e.g., hypo- or hypernatremia, hypo- or hyperkalaemia) and 
acid-base disturbances (e.g., contraction alkalosis, metabolic acidosis) which may 
affect choice of replacement fluid and rate of repletion. In some cases, an arterial 
blood gas may be needed if mixed acid-base disturbance is suspected.  
 
Fluid Resuscitation 
It is suggested that fluid resuscitation should be commenced immediately to restore 
circulating volume and improve cardiac output. NICE (2017) advise that crystalloids 
are most appropriate, unless the patient presents with active internal or external 
bleeding. In such cases, Red Blood Cells should be transfused as the patient would 
require haemoglobin to support the transportation around the body to prevent 
anaerobic respiration and cell death causing increase lactate (Dutton and Finch, 
2018).  Highlight carriage problems earlier and that respiratory rate and SaO2 may indicate 
this issue. 
 
Use of Crystalloids (NICE, 2017) 




NICE (2017) recommend the administration of intravenous (IV) crystalloids that 
contain sodium in the range 130–154 mmol/l, with a bolus of 500 ml over less than 
15 minutes. (For more information, see the Composition of commonly used 
crystalloids - table 1.) 
 
Table 1: Composition of commonly used crystalloids (NICE, 2017) Editor – Please 
redraw.  
 
Complications (Rull and Bonsall, 2017)  
Complication  Wider implication  
Blood is directed away from the kidneys 
and gut 
 
This can produce acute kidney injury 
and complications of gut ischaemia 




Inadequate perfusion  This leads to hypoxia and metabolic 
acidosis 
About 75% of the blood flow to the right 
ventricle and 100% to the left ventricle 
occurs in diastole 
A fall in diastolic pressure will 
predispose to cardiac arrhythmias and 
even arrest. Upset of acid-base 
balance, hypoxia and disturbance of 
electrolytes will aggravate the problem 
 
In those who are susceptible, 
dehydration 
This may lead to haemoconcentration 
and sludging of the circulation with such 






Following the infusion of either crystalloids (fluid loss) or RBC’s (after blood loss), the 
patients vital signs should be remeasured. It is imperative that the patient has a 
normotensive blood pressure to perfuse the brain, heart, lungs and kidneys 
particularly, as otherwise they are likely to develop an Acute Kidney Injury or go into 
shock (REF).  This is the goal of fluid resuscitation and has no mention of vasoactive drugs.  
 
Consider the audience for this paper. These drugs are most often administered in critical care areas. 
 
Pearls and Other Issues (Taghavi and Askari, 2019) 




In patients with hypovolemic shock due to extracellular fluid loss, the aetiology of 
fluid loss must be identified and treated. 
Monitoring electrolytes and acid/base status in patients in hypovolemic shock is of 
utmost importance. 
Trauma is the leading cause of haemorrhagic shock. 
The haemorrhagic shock should be treated with balanced transfusion of packed red 
blood cells, plasma, and platelets. 
Determining whether patients will be responsive to volume resuscitation should not 
rely on a single modality such as ultrasound, pulse pressure wave variation, passive 
leg raises, or central venous pressure. The decision for fluid administration should be 
based on a complete systematic assessment to help direct volume resuscitation.  
For patients with hypovolemic shock due to fluid loss, the crystalloid solution is 
preferred over colloid. 
 
Training and education (NICE, 2017) 
Hospitals should establish systems to ensure that all healthcare professionals 
involved in prescribing and delivering IV fluid therapy are trained on the principles 
covered in this guideline, and are then formally assessed and reassessed at regular 
intervals. Health care professionals need to be able to assess, identify and escalate 
care. Competence must be demonstrated in:   
 
• understanding the physiology of fluid and electrolyte balance in patients with 
normal physiology and during illness 
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• assessing patients' fluid and electrolyte needs (the 5 Rs: Resuscitation, 
Routine maintenance, Replacement, Redistribution and Reassessment) 
• assessing the risks, benefits and harms of IV fluids 
• prescribing and administering IV fluids 
• monitoring the patient response 
• evaluating and documenting changes and 
• taking appropriate action as required. 
• Hospitals should have an IV fluids lead, responsible for training, clinical 
governance, audit and review of IV fluid prescribing and patient outcomes. 
Conclusion 
Hypovolemic shock is characterised by an imbalance between oxygen supply and 
demand. If left untreated patients can develop ischemic injury of vital organs, which 
leads to multi-system organ failure. It is important for nurses to be able to assess, 
identify and escalate care to ensure patients receive correct and timely treatment.  
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